LONGITY NMN-C® SUPPLEMENT

Unlock your
cellular repair

A cellular approach to healthspan

Dr. Eric verdin & alessia grozio interview

Learn more about NMN-C® and NAD+ in this video interview.

THE MOST ADVANCED NMN FOR HEALTHCARE PROFESSIONALS

NMN-C® is 99.6% pure, highly stable and proven to have a higher tolerability than other molecules promoted as NAD+ boosters. NMN-C® brings pharmaceutical-grade technology, unmatched levels of scientific rigor and transparency to cellular optimization solutions.

Longity is designed to leverage a direct uptake pathway that transports NMN across cell membranes directly into the cell via the Slc12a8a enzyme. Slc12a8 is a gene encoding NMN transporter with a critical role in regulating intestinal NAD+ metabolism.

An OECD 408 toxicology study – the first of its kind to be undertaken on Nicotinamide Mononucleotide NMN –demonstrated NMN-C® has a NOAEL tolerance level 3x higher than Nicotinamide Riboside NR and almost 7x higher than Nicotinamide NAM.

Recommended by leading physicians

Dr Frank Lipman, MD

Leader in Functional Medicine.

Eric Verdin, MD

President of the Buck Institute for Aging research.

Pr Olivier Rascol

A neurologist specialized in Movement Disorders, Professor of Clinical Pharmacology at the Toulouse University Hospital since 1993.